Home / Inspections / 1027891

FDA Inspection 1027891 — Southern California Reproductive Center Medical Group PC

Southern California Reproductive Center Medical Group PC — FEI 3003489225

The FDA completed an inspection of Southern California Reproductive Center Medical Group PC on August 24, 2017 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Beverly Hills, CA (United States)

Facility

Other inspections at this facility

  • 1275017 (VAI Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1178423 (NAI Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904200 (NAI Thu Nov 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 732541 (VAI Fri Jun 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources